ClinicalTrials.gg
Sign In
CompletedNCT07157046Updated Sep 5, 2025

Association of Q Angle and Bunion Deformity of High Heel Wearing Females of Office Working in Lahore

An observational study in Bunion (Diagnosis), sponsored by Superior University. Completed at 1 site in Pakistan. Open to female participants aged 18 Years to 36 Years. Per ClinicalTrials.gov, last updated 2025-09-05.

Sponsored by Superior University · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
80
Ages
18 Years to 36 Years
Sex
Female
01

Study summary

Q angle was measured in association with wearing high heels in working women in offices located in Lahore. The measurement tool was Manchester scale and goniometer with a sample size of 80 people.

02

Conditions studied

  • Bunion (Diagnosis)

Browse trials for

03

In context

Bunion

58 studies on the registry are indexed under Bunion; 5 are open to participants now.

This study's enrollment of 80 is above the median of 40 across 10 observational studies indexed under Bunion.

Browse Bunion studies →

Lead sponsor

Superior University is the lead sponsor of 253 studies on the registry; 25 are open to participants now.

Browse Superior University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 36 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Q angle was measured in association with wearing high heels in working women in offices located in Lahore

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-36 age
  • Female
  • Single leg affected
  • High heel wearing

Exclusion criteria

Exclusion Criteria:

  • Any neurological condition
  • Any laxity
  • Leg length discrepancy
  • Previous fracture
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
80 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Manchester scale

    It refers to two different medical assessment tools: the Manchester Scale for Hallux Valgus, which grades foot deformity severity using photographs from no deformity (Grade 1) to severe deformity (Grade 4)

    Time frame: 6 Month

07

Study locations

1 site
  • Offices in Johar Town
    Lahore, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2024 to primary completion in Feb 2025, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 28, 2025
First posted
Sep 5, 2025
StartActual
Nov 1, 2024
Primary completionActual
Feb 1, 2025
CompletionActual
Apr 1, 2025
Last update
Sep 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07157046
Lead sponsor
Superior University
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
Sep 5, 2025
Start date
Nov 1, 2024
Primary completion
Feb 1, 2025
Completion
Apr 1, 2025
Last update
Sep 5, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Bunion →

Other studies from this sponsor

Superior University →

Start the discussion